Ovarian Cancer Clinical Trial
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)
All subjects must be enrolled within 90 days of diagnosis
No prior treatment for ovarian carcinoma
All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon
Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan
Proficiency in English in the determination of the investigators of by patient self-report
Patient under age 18
Prior treatment for ovarian cancer
Second opinion visit only
Immediate surgery plan without neoadjuvant treatment
No intended surgical plan
Chemotherapy administration exclusively planned at MSKCC regional site
Patient unwilling to sign consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.